Dr. Ashley Brooke Graul, MD

Dr. Graul practices at St Lukes University Hospital Bethlehem in Bethlehem, Pennsylvania.

Dr. Graul's NPI, 1538427406, was assigned on April 30, 2012. Dr. Graul graduated from Temple University School of Medicine in 2012. Dr. Graul holds Pennsylvania license MD457669.

Dr. Graul's primary practice is St Lukes University Hospital Bethlehem, at 801 Ostrum St, Bethlehem, PA 18015 in Northampton County. The practice phone is (610) 954-4000.

Dr. Graul's primary practice is St Lukes University Hospital Bethlehem in Bethlehem, Pennsylvania. Dr. Graul is also affiliated with St. Luke's University Hospital - Bethlehem Campus. The medical group on file is St. Luke's South Mountain Family Practice. Dmand AI also links Dr. Graul to 3 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Graul practices, 7 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Graul's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Graul is licensed in Pennsylvania.

CMS data shows 523 Medicare services from Dr. Graul across 10 procedure codes in 2024, for 150 Medicare patients. Medicare paid $47,948 for them.

CMS counts 150 Medicare patients who saw Dr. Graul in 2024. The largest group is 65 to 74, with 74 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Graul's median patient age at 65, with 100% women.

In 2024, Dr. Graul wrote 119 Medicare Part D claims for 69 patients. 88% of them were for generic drugs. CMS names the drug for 32 of them, across 1 drug with 11 or more claims each, at $66 in total drug cost. In 2023, CMS named 90 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Graul for performance year 2024, reported through an alternative payment model (APM). Dr. Graul accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Graul as offering telehealth. CMS counts 19 procedures of removal of the uterus by Dr. Graul, more than 92% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 16 papers to Dr. Graul, published from 2011 to 2025. 2025 was the busiest year, with 3. The most frequent topics are Hysterectomy, Genital Neoplasms, Female and Uterine Cervical Neoplasms. Dr. Graul has published most often in Gynecol Oncol. Dr. Graul's most frequent co-authors are Emily M. Ko, MD, Robert A. Burger, MD and Allison Renee Walker.

CMS Open Payments shows 22 general payments to Dr. Graul from 9 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 51% of the total. Genmab U.S., Inc. paid the most, $1,799.

Dr. Graul graduated from Temple University School of Medicine in 2012.